Patexia Community

Innovation, Technology, and IP News

Fresh From the Bench: Latest Federal Circuit Court Case

CASE OF THE WEEK Hologic, Inc. v. Minerva Surgical, Inc., Appeal Nos. 2019-2054, -2081 (Fed. Cir. Aug. 11, 2022) Our Case of the Week follows the Hologic saga as it returns to the...

Feed tagged as "pharmaceutial industry":
This morning we released our third annual ANDA Litigation Intelligence Report. The report covers high-level statistics related to Hatch-Waxman... Read More »
In early 1983, Bolar Pharmaceutical Inc. wanted to bring a generic version of the Dalmane drug, a sleeping pill, to the market. At that... Read More »
  Small molecule drugs have been the norm for much of medicine’s history. Only in the past decade has there been a rise ... Read More »
Last week, a bipartisan group of six U.S. senators sent a letter to USPTO asking to take measures in order to combat patent thickets... Read More »
The pandemic we just went through was one of the examples of how important is the patent system in strengthening the public health... Read More »
Market intelligence is especially critical to sound pharmaceutical investing Pharmaceutical investing is both challenging and potentially very rewarding, but it... Read More »
Grant funding for scientists at public and private institutions is as competitive and selective as it has ever been. An article in Science magazine earlier this year... Read More »
Daniel PorterThe history of scientific discovery is fraught with aberrations in the way science is "supposed" to go, and it seems cancer research is no exception. Many breakthrough discoveries have significant non-scientific "ulterior motives" -- maybe we need to embrace this reality and create a system that controls for it rather than fights against it?
May 23, 2012
Piramal Healthcare, a global business conglomerate stationed in Mumbai, Indian, is acquiring Decision Resources, a US-based intellectual property and knowledge-based... Read More »